Now you are 2 for 2
dndn disappointed us because they can't turn a profit and don't expect to.
but euro approval is more likely than not and you predicted not.
so your own predictor is likely just as bad, lol.
bcrx doing fine since the 1's and 2's, thank you.
achn in the wings .
we'll see how weasl's Biod does, hope it does well.
and the stock of no name goes on and on
as the wheels spin round n round as Kirkman pumps us into the next dilution.
Is the product approved in Europe? Is this Co going bankrupt? You don't have the class to say yes Van 120K drugs don't sell if they don't save most peoples lives. You understand price demand curves and I don't .Dumb as dirt